Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.01 USD | -0.60% | +0.72% | -2.71% |
02:25pm | Pfizer and AstraZeneca announce new investments of nearly $1 billion in France | RE |
11:49am | Pfizer announces 500 million euros investment in France | RE |
Financials (USD)
Sales 2024 * | 60.41B | Sales 2025 * | 62.71B | Capitalization | 159B |
---|---|---|---|---|---|
Net income 2024 * | 7.78B | Net income 2025 * | 11.29B | EV / Sales 2024 * | 3.59 x |
Net Debt 2024 * | 58.11B | Net Debt 2025 * | 49.97B | EV / Sales 2025 * | 3.33 x |
P/E ratio 2024 * |
19.5
x | P/E ratio 2025 * |
13.7
x | Employees | 88,000 |
Yield 2024 * |
5.96% | Yield 2025 * |
6.07% | Free-Float | 59.05% |
Latest transcript on Pfizer, Inc.
1 day | -0.60% | ||
1 week | +0.72% | ||
Current month | +9.33% | ||
1 month | +6.34% | ||
3 months | +1.63% | ||
6 months | -4.99% | ||
Current year | -2.71% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 0 M€ | +12.39% | - | |
9.37% | 0 M€ | +7.69% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 28.01 | -0.60% | 25,849,775 |
24-05-09 | 28.18 | -0.32% | 47,831,087 |
24-05-08 | 28.27 | +1.80% | 39,087,790 |
24-05-07 | 27.77 | -1.38% | 65,606,379 |
24-05-06 | 28.16 | +1.26% | 59,899,707 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.71% | 159B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- PFE Stock